These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 16959589)

  • 41. [Clinical manifestations of insulin resistance. The hormonal-metabolic syndrome X (5H), its prevalence and impact on cardiovascular morbidity and mortality. I].
    Hrnciar J; Hrnciarová M; Jakubíková K; Okapcová J
    Vnitr Lek; 1992 May; 38(5):426-37. PubMed ID: 1509712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation.
    Caballero AE
    Arch Med Res; 2005; 36(3):241-9. PubMed ID: 15925014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diabetes mellitus and epidemiology: apropos of the meeting on the epidemiology of diabetes mellitus].
    Simon D
    Pathol Biol (Paris); 1994 Feb; 42(2):129-32. PubMed ID: 8090556
    [No Abstract]   [Full Text] [Related]  

  • 44. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stress in women: metabolic syndrome and polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F
    Ann N Y Acad Sci; 2006 Nov; 1083():54-62. PubMed ID: 17148733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].
    Szpringer EA; Lutnicki KR; Zych IS
    Wiad Lek; 2006; 59(11-12):848-54. PubMed ID: 17427503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity and polycystic ovary syndrome.
    Vrbikova J; Hainer V
    Obes Facts; 2009; 2(1):26-35. PubMed ID: 20054201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
    Diamanti-Kandarakis E; Christakou C; Kandarakis H
    Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L; Teede H
    Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The metabolic syndrome in women.
    Schneider JG; Tompkins C; Blumenthal RS; Mora S
    Cardiol Rev; 2006; 14(6):286-91. PubMed ID: 17053375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications.
    Taylor AE
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 2):S94-S100. PubMed ID: 9855615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Polycystic ovarian disease. 1. The current data on its etiology and pathogenesis].
    Rachev E
    Akush Ginekol (Sofiia); 1999; 38(2):42-5. PubMed ID: 10730388
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of appropriate patients for cardiometabolic risk management.
    Peters AL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ; Hutchison SK; Zoungas S
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polycystic ovary syndrome in obese adolescents.
    Stanley T; Misra M
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):30-6. PubMed ID: 18185060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular risk in women with polycystic ovary syndrome.
    Cho LW; Atkin SL
    Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?
    Daskalopoulos GN; Karkanaki A; Karagiannis A; Mikhailidis DP; Athyros VG
    Angiology; 2011 May; 62(4):285-90. PubMed ID: 21474465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.